In recent years, private equity firms have risen to the forefront of the conversation around healthcare innovation and, in the process, firmly established themselves as drivers for change.
Obamacare, Trump Care or no care? The debate about who pays to keep America healthy rages on with no end in sight. It might even become a huge talking point in the next presidential election, as some are pushing for Medicare-for-all coverage. Confused? I know I am. Here is the first of a series of summaries about US health care.
Obamacare, Trump Care or no care? The debate about who pays to keep America healthy rages on with no end in sight. It might even become a huge talking point in the next presidential election, as some are pushing for Medicare-for-all coverage. Confused? I know I am. Here is the first of a series of summaries about US health care.
Enhance Healthcare Analytics with Consumer DataRay Pun
To succeed in the new value-based care landscape, healthcare providers must expand beyond traditional data sources for healthcare analytics. Leading providers are using consumer data, available at the individual and household level, to supplement clinical and claims data. By integrating consumer insights into models for understanding and predicting patient health, providers can improve the health of Americans and achieve these outcomes:
• Improve community health needs assessments
• Drive patient retention and engagement with personalized
wellness programs
• Reduce patient readmission rates
Mercer Capital's Value Focus: Healthcare Facilities | Year-End 2017Mercer Capital
Mercer Capital's Healthcare Facilities Industry newsletter provides perspective on valuation issues. Each newsletter also includes macroeconomic trends, industry trends, and guideline public company metrics.
Dallas health insurance agent say premium increases are because the cost of c...jthorn4
Rick Thornton, a Dallas health insurance agent, said premium increases are because the cost of care is increasing, adding that there has been a 9.1% increase from when the ACA was first introduced in 2010.
A consumer study prepared by PwC to investigate how behavioral, regulatory, and technological disruption are changing consumer's approaches to managing their health.
Provider/payor convergence: A prescription for growth?Grant Thornton LLP
As bottom lines shrink, payors and providers are beginning to see convergence, or vertical integration, as the path to growth, Panelists from Johns Hopkins Institutions, Buchanan Ingersoll & Rooney PC and Grant Thornton LLP share their experience.
Government data shows rising OOP spending for consumers, but excludes some types of health-related items and services that can add significantly to the total amount and consumer share of spending. This infographic exposes these “hidden costs” that account for almost one-fifth of total health care spending.
For more information, visit
Imagine a future in which more consumers engage with the health care system – a future that holds the promise of more effective, efficient, and satisfying care experiences and better health outcomes for those individuals and the accountable care populations to which they belong. Findings from Deloitte’s 2015 Survey of US Health Care Consumers suggest we are moving closer to that future as consumer engagement increases in three important areas. Explore trends in consumers’ use of online resources and health technologies: http://www2.deloitte.com/us/en/pages/life-sciences-and-health-care/articles/health-care-consumer-engagement.html.
The positions of the presidential candidates on healthcare and the Affordable Care Act (ACA) are noteworthy as healthcare consumes $3 trillion, almost $10,000 for every man, woman and child in the United States.
Did you have time to read the 1,990 page healthcare bill that was recently passed through Congress? Have you since wondered about the impact that massive bill will have on the average American, health insurance providers, business owners and YOU? If yes, then join the Young Professionals of Chicago as we host a panel of diverse health care professionals that will be discussing current healthcare reform and taking questions on the impact of the United States' new healthcare policy. The distinguished panelists will also provide some insight and clarity into what this massive bill means for individuals like you. There will also be an opportunity for open networking with other young professionals before and after the discussion.
Will Price Transparency Help Patients Find Lower Cost Care Mary Tolan
At the close of July, the Trump administration proposed new policies that would create greater price transparency among healthcare providers. The driving idea behind the new proposal is that patients will be better able to shop around for care and choose options that fit within their budgetary limits instead of seeking care from the nearest provider and hoping that the bill they receive after the fact isn’t out of their financial reach. It’s a measure meant to empower and facilitate cost-savings for overburdened consumers — and given the current sky-high state of healthcare prices in the United States, it may well be a welcome one.
While hospitals have dealt with new regulations and declining payments, today’s CEOs face many unprecedented challenges. New survey findings from the Deloitte Center for Health Solutions reveal top of mind issues for health system CEOs regarding the current state of the industry and their expectations and plans as they look to the future. For more, please visit: www.deloitte.com/us/health-system-ceos.
Consumer-Centric Healthcare: 2015--The Tipping Point Has Arrived (Report by William Blair)
Consumers—in tandem with disruptive healthcare technology and healthcare services providers—are the key to solving many of US healthcare's woes, particularly the unsustainably high cost of care.
Public exchanges, private exchanges, and high-deductible health plans are growing quickly. Disruptive forces of competition will create a lower-cost system that promotes the growth of highly efficient, low-cost, and high-quality providers and technologies.
The continued movement of financial and quality risk back to providers (and increasingly to consumers themselves) is encouraging providers and consumers to seek preventive medicine, cost efficiency, clinical efficacy, and overall value in healthcare. In turn, this could drive significant change regarding the primary point of care delivery (rapidly moving outside the hospital), the overall cost of healthcare and investment decisions made by healthcare providers.
Consumer-centric healthcare providers will experience strong top- and bottom-line growth over the coming years. Investors in both the public and private-equity markets will achieve superior long-term returns by identifying and investing in these companies.
Enhance Healthcare Analytics with Consumer DataRay Pun
To succeed in the new value-based care landscape, healthcare providers must expand beyond traditional data sources for healthcare analytics. Leading providers are using consumer data, available at the individual and household level, to supplement clinical and claims data. By integrating consumer insights into models for understanding and predicting patient health, providers can improve the health of Americans and achieve these outcomes:
• Improve community health needs assessments
• Drive patient retention and engagement with personalized
wellness programs
• Reduce patient readmission rates
Mercer Capital's Value Focus: Healthcare Facilities | Year-End 2017Mercer Capital
Mercer Capital's Healthcare Facilities Industry newsletter provides perspective on valuation issues. Each newsletter also includes macroeconomic trends, industry trends, and guideline public company metrics.
Dallas health insurance agent say premium increases are because the cost of c...jthorn4
Rick Thornton, a Dallas health insurance agent, said premium increases are because the cost of care is increasing, adding that there has been a 9.1% increase from when the ACA was first introduced in 2010.
A consumer study prepared by PwC to investigate how behavioral, regulatory, and technological disruption are changing consumer's approaches to managing their health.
Provider/payor convergence: A prescription for growth?Grant Thornton LLP
As bottom lines shrink, payors and providers are beginning to see convergence, or vertical integration, as the path to growth, Panelists from Johns Hopkins Institutions, Buchanan Ingersoll & Rooney PC and Grant Thornton LLP share their experience.
Government data shows rising OOP spending for consumers, but excludes some types of health-related items and services that can add significantly to the total amount and consumer share of spending. This infographic exposes these “hidden costs” that account for almost one-fifth of total health care spending.
For more information, visit
Imagine a future in which more consumers engage with the health care system – a future that holds the promise of more effective, efficient, and satisfying care experiences and better health outcomes for those individuals and the accountable care populations to which they belong. Findings from Deloitte’s 2015 Survey of US Health Care Consumers suggest we are moving closer to that future as consumer engagement increases in three important areas. Explore trends in consumers’ use of online resources and health technologies: http://www2.deloitte.com/us/en/pages/life-sciences-and-health-care/articles/health-care-consumer-engagement.html.
The positions of the presidential candidates on healthcare and the Affordable Care Act (ACA) are noteworthy as healthcare consumes $3 trillion, almost $10,000 for every man, woman and child in the United States.
Did you have time to read the 1,990 page healthcare bill that was recently passed through Congress? Have you since wondered about the impact that massive bill will have on the average American, health insurance providers, business owners and YOU? If yes, then join the Young Professionals of Chicago as we host a panel of diverse health care professionals that will be discussing current healthcare reform and taking questions on the impact of the United States' new healthcare policy. The distinguished panelists will also provide some insight and clarity into what this massive bill means for individuals like you. There will also be an opportunity for open networking with other young professionals before and after the discussion.
Will Price Transparency Help Patients Find Lower Cost Care Mary Tolan
At the close of July, the Trump administration proposed new policies that would create greater price transparency among healthcare providers. The driving idea behind the new proposal is that patients will be better able to shop around for care and choose options that fit within their budgetary limits instead of seeking care from the nearest provider and hoping that the bill they receive after the fact isn’t out of their financial reach. It’s a measure meant to empower and facilitate cost-savings for overburdened consumers — and given the current sky-high state of healthcare prices in the United States, it may well be a welcome one.
While hospitals have dealt with new regulations and declining payments, today’s CEOs face many unprecedented challenges. New survey findings from the Deloitte Center for Health Solutions reveal top of mind issues for health system CEOs regarding the current state of the industry and their expectations and plans as they look to the future. For more, please visit: www.deloitte.com/us/health-system-ceos.
Consumer-Centric Healthcare: 2015--The Tipping Point Has Arrived (Report by William Blair)
Consumers—in tandem with disruptive healthcare technology and healthcare services providers—are the key to solving many of US healthcare's woes, particularly the unsustainably high cost of care.
Public exchanges, private exchanges, and high-deductible health plans are growing quickly. Disruptive forces of competition will create a lower-cost system that promotes the growth of highly efficient, low-cost, and high-quality providers and technologies.
The continued movement of financial and quality risk back to providers (and increasingly to consumers themselves) is encouraging providers and consumers to seek preventive medicine, cost efficiency, clinical efficacy, and overall value in healthcare. In turn, this could drive significant change regarding the primary point of care delivery (rapidly moving outside the hospital), the overall cost of healthcare and investment decisions made by healthcare providers.
Consumer-centric healthcare providers will experience strong top- and bottom-line growth over the coming years. Investors in both the public and private-equity markets will achieve superior long-term returns by identifying and investing in these companies.
Good Foundations: Building Healthcare M&A and Real EstateDuff & Phelps
Several fundamental shifts have changed the face of healthcare in North America. A new report, “Good Foundations: Building Healthcare M&A and Real Estate,” published in association with Mergermarket, explores the way healthcare companies are increasingly embracing innovative ways to raise capital and fund future projects, including selling real estate assets to third-party capital providers.
Health insurance exchanges critical success factors for payersApoorv S
Health insurance exchanges will significantly impact the healthcare entities and more so the payers. Payers will have to align with the change in focus from B2B model to B2C model and this entails payers to focus on various aspects to succeed. Article outlines key success factors which payers will have to factor in to tide over the changing fundamentals of U.S. healthcare due to the shift towards retail healthcare.
A look at the trends, populations and products at play.
More questions than answers face a health industry in flux grappling with new meanings of cost, value, compliance and care delivery. Different stakeholder groups offer up different answers as they accelerate to keep pace with medical innovation. Providers, payers and businesses serving healthcare are being asked to incorporate and act on new data, integrate with new platforms and pioneer new offerings to create an increasingly accessible, connected experience. What’s driving the adaptation, and what trends are worth acting on?
Healthcare systems around the world are fraught with challenges that reveal the cracks in today's operating models. But a nascent trend that is quickly becoming an imperative is poised to transform the industry: the consumerization of healthcare. By promoting and supporting more control, awareness, and responsibility on the part of the consumer, healthcare companies can drive a dramatic improvement in population health and reduction in costs.
The Rising Costs of Medical Bills Vest 2017Cameron Leids
Medical Bills and Healthcare costs have been increasing. Vest walks you through the current trends across the industry and what needs to be done in order to combat them.
During the 2018 mid-term elections, candidates faced off making big claims that they would be the ones to fix healthcare. Now that they are back to work, what can we anticipate with a new Congress? Will we finally see improvements or gridlock? Join Bobbi Brown, MBA and Stephen Grossbart, PhD as they tackle these questions along with a 2018 lookback of what went right and 2019 predictions of the most important trends that will impact our daily work.
Beyond political maneuvering, in 2018 we saw material changes in the business of healthcare. The pace of mergers, acquisitions and partnerships was strong and deals like the pending acquisition of Aetna by CVS, could dramatically impact patient behavior and revenue streams. In addition, the Center for Medicare & Medicaid Services (CMS) continues to support existing programs while adding new measures to support transparency, interoperability and a continued shift to value-based payments. What does this mean for your organization in 2019? View this webinar to learn more across these areas:
- The business of healthcare including new market entrants, business models and shifting strategies to stay competitive.
- Continuous quality and cost control monitoring across populations.
- CMS proposals to push ACOs into two-sided risk models.
- Historic changes to Merit-based Incentive Payment System (MIPS).
- Fewer process measures but more quality outcomes scrutiny for providers.
- Increased consumer demand for more transparency.
There are many challenges and opportunities for all of us in healthcare. Join Bobbi and Stephen as they draw upon their decades of experience to make sense of the past year and look ahead to give you guidance for the new year. This is the fourth year running that Bobbi has presented her predictions at the turn of the new year and past attendees will remember that her knack for predicting is uncanny and her stories are unforgettable. This time was no different.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
2. In recent years, private equity firms have risen to the
forefront of the conversation around healthcare innovation
and, in the process, firmly established themselves as drivers
for change.
Their growing interest in guiding healthcare into the future
speaks clearly through their increasing investments. In 2018,
the number of global private equity-backed healthcare deals
saw an uptick of nearly 50 percent to $63.1 billion — a figure
which, as a 2019 report from Bain & Company notes,
represents the highest level of investment in healthcare
since 2006.
There are a few clear reasons for this high level of interest.
First, private equity organizations see an opportunity to
improve healthcare quality and patient experience while
streamlining operations for care organizations and
increasing business profitability. As one writer sums up the
matter in an article for Health Affairs, “Private equity
investors are […] attracted to health care services because
some parts of the existing health care delivery system have
not adequately addressed growing cost concerns, demand
for quality, and consumers’ preferences.”
3. All this said, some sub-sectors of the healthcare industry have seen more investor interest than others. The Bain & Co. report
mentioned above found that provider deals consistently led domestic and international investments, with $23.2 billion
allocated across 84 domestic transactions and $35 billion earmarked across 159 global deals. However, other sectors have
seen similar levels of interest; these include physician groups, behavioral and retail health, and home health care.
The last has garnered particular attention in recent years. In 2018, two private equity firms — TPG Capital and Welsh, Carson,
Anderson & Stowe — made headlines when they partnered with the insurance giant Humana to acquire and divide the
hospital and home health organization Kindred at Home. The deal divided the company; while the two private equity firms
would own Kindred’s hospital business, ownership of the home healthcare business would fall 60% and 40% between the
private equity firms and Humana, respectively.
4. The idea that drove the partnership was simple: the trio believed that if
they could engage with patients across more of the care continuum,
they would be better able to optimize care, manage outcomes, and
control costs. Moreover, they could do so over a broad scale:
according to Home Health News, Kindred at Home stands as the
largest home health company in the United States, encompassing over
600 sites and 40,000 caregivers.
The deal was valuable for Humana, given that the insurer serves a
large population of aging Medical Advantage beneficiaries who could
benefit from Kindred’s home healthcare services. However, the
Kindred deal also offered considerable value to the private equity firms
— and served as an example of a broader trend towards home health
in the private equity space.
Home healthcare is a burgeoning field — one well-suited to private
equity support. A recent report published by Business Insider
Intelligence indicates that the home healthcare market in the U.S. is on
track to achieve a value of $173 billion by 2026. The sector’s annual
growth rate tops 7 percent — well above those in physician services
(5.6 percent) and hospital care (5.3 percent).
5. This rampant growth is due in part to demographic, social, and economic shifts. Over the next several years, the number of aging
Boomers who could benefit from home healthcare will continue to rise — especially as more turn to wearables to track their health
and prioritize independent living. According to statistics published via CapitalRoundtable, a full 88 percent of health systems and
hospitals plan to or have already invested in remote patient monitoring technologies as part of their transition to value-based health.
As the deal for Kindred at Home demonstrates, private equity will have a prominent role in rethinking how the healthcare sector
provides home health care. Their interventions can and likely will speed the shift towards value-based care, improve quality, and
lower care costs — all while growing profits.
It’s a trend that will benefit all — from patients to providers to private equity investors.